Inhaled DMT for major depression
Treatments studied
Part of Mental health clinical trials.
This trial tests if inhaling DMT can help treat moderate to severe major depression. You may qualify if your depression has lasted at least two weeks and you have not changed medications recently.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older and can make your own decisions.
- You have a diagnosis of major depression with moderate to severe symptoms.
- Your current episode has lasted at least two weeks.
- You have not changed antidepressants or other depression treatments in the past 4 weeks.
- You have not used any psychedelics (like LSD, psilocybin, or DMT) in the past 14 days.
- You do not have serious heart, liver, or kidney problems, or uncontrolled health issues like high blood pressure or diabetes.
- You are not pregnant, breastfeeding, or planning to become pregnant, and you will use effective birth control.
- You do not have a history of psychosis, bipolar disorder, or certain personality disorders.
- You do not have current substance use problems (except nicotine or caffeine).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a single dose of psilocybin, given while you are under anesthesia, can help treat major depression. You will be monitored closely during and after the session.
This study tests whether a combination of psilocybin (a psychedelic substance) and transcranial magnetic stimulation (rTMS, a noninvasive brain stimulation) can help people with treatment-resistant depression. It involves daily visits to the research center for about 2 weeks.
This trial tests an experimental nasal spray for people with major depression who are currently having suicidal thoughts. It aims to see if the spray can quickly reduce depression and suicidal feelings.
This study tests a combination medication (dextromethorphan plus bupropion) to see how it affects brain activity in people with moderate-to-severe depression. Researchers use brain imaging (fMRI) to understand how the drug works and whether it may help relieve depression symptoms.
This study tests whether a combination of DMT (a psychedelic) and propofol (a sedative) can help treat depression. You will receive both medicines in a hospital setting, and the team will monitor your response.
This trial studies the safety and effects of DMT, a psychedelic compound, in healthy volunteers and people with major depressive disorder (MDD) who haven't responded well to antidepressants. It aims to see how DMT affects the brain and mood.
Hear when a new MDD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.